Browse the full insider trade history of Press Ganey Holdings, Inc., a publicly traded company based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was filed on 3 February 2016 (Cession). Among the most active insiders: Riskind Patricia L.. Every trade is free.
Analysts rate Press Ganey Holdings, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Press Ganey Holdings, Inc. is a company focused on enhancing patient experience and healthcare performance. It provides measurement and analytics solutions to help healthcare organizations improve care quality.